Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000728804 | SCV000856420 | uncertain significance | not provided | 2017-08-16 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001147600 | SCV001308434 | uncertain significance | Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Ambry Genetics | RCV004020429 | SCV004970051 | uncertain significance | Inborn genetic diseases | 2023-11-29 | criteria provided, single submitter | clinical testing | The c.968G>A (p.R323Q) alteration is located in exon 9 (coding exon 9) of the TRMU gene. This alteration results from a G to A substitution at nucleotide position 968, causing the arginine (R) at amino acid position 323 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Department of Pathology and Laboratory Medicine, |
RCV005396598 | SCV006053174 | uncertain significance | Aminoglycoside-induced deafness; Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins | 2022-08-09 | criteria provided, single submitter | research |